Dr. Michael Depaolis, O.D

NPI: 1720084346
Total Payments
$40,349
2024 Payments
$193.53
Companies
20
Transactions
58
Medicare Patients
1,273
Medicare Billing
$83,168

Payment Breakdown by Category

Research$30,483 (75.5%)
Other$5,020 (12.4%)
Food & Beverage$3,049 (7.6%)
Travel$1,060 (2.6%)
Consulting$700.00 (1.7%)
Education$37.65 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $30,483 7 75.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,020 4 12.4%
Food and Beverage $3,049 40 7.6%
Travel and Lodging $1,060 5 2.6%
Consulting Fee $700.00 1 1.7%
Education $37.65 1 0.1%

Payments by Type

Research
$30,483
7 transactions
General
$9,866
51 transactions

Top Paying Companies

Company Total Records Latest Year
Bausch Health US, LLC $30,483 7 $0 (2020)
Shire North American Group Inc $5,511 11 $0 (2018)
CooperVision Inc. $1,332 9 $0 (2023)
Kala Pharmaceuticals, Inc. $886.86 3 $0 (2021)
Sun Pharmaceutical Industries Inc. $320.96 3 $0 (2022)
Novartis Pharmaceuticals Corporation $242.89 3 $0 (2021)
Sight Sciences, Inc. $241.84 3 $0 (2022)
Thea Pharma Inc. $202.19 2 $0 (2024)
Bausch & Lomb Americas Inc. $200.83 2 $0 (2024)
Alcon Vision LLC $171.38 4 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $193.53 2 Thea Pharma Inc. ($97.82)
2023 $535.22 5 Horizon Therapeutics plc ($124.99)
2022 $303.30 3 Sight Sciences, Inc. ($112.20)
2021 $1,279 8 Kala Pharmaceuticals, Inc. ($886.86)
2020 $6,529 13 Bausch Health US, LLC ($5,346)
2019 $25,495 9 Bausch Health US, LLC ($25,137)
2018 $234.42 4 GENZYME CORPORATION ($109.02)
2017 $5,779 14 Shire North American Group Inc ($5,486)

All Payment Transactions

58 individual payment records from CMS Open Payments — Page 3 of 3

Date Company Product Nature Form Amount Type
07/07/2017 Shire North American Group Inc XIIDRA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $880.00 General
Category: OPTHALMICS
04/21/2017 Shire North American Group Inc XIIDRA (Drug) Travel and Lodging In-kind items and services $96.30 General
Category: OPTHALMICS
04/21/2017 Shire North American Group Inc XIIDRA (Drug) Travel and Lodging In-kind items and services $5.00 General
Category: OPTHALMICS
04/13/2017 Rapid Pathogen Screening, Inc. InflammaDry (Device) Food and Beverage Cash or cash equivalent $14.27 General
Category: Medical Device
04/07/2017 Shire North American Group Inc XIIDRA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,630.00 General
Category: OPTHALMICS
03/22/2017 Shire North American Group Inc XIIDRA (Drug) Food and Beverage In-kind items and services $83.43 General
Category: OPTHALMICS
03/02/2017 Shire North American Group Inc XIIDRA (Drug) Education In-kind items and services $37.65 General
Category: OPTHALMICS
02/24/2017 Shire North American Group Inc XIIDRA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $880.00 General
Category: OPTHALMICS

Research Studies & Clinical Trials

Study Name Company Amount Records
A STUDY TO EVALUATE THE SAFETY, EFFECTIVENESS AND PRODUCT PERFORMANCE OF THE BIOTRUE ONEDAY FOR ASTIGMATISM SOFT CONTACT LENS WHEN WORN ON A DAILY BASIS Bausch Health US, LLC $25,137 3
A STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE BIOTRUE ONEDAY FOR ASTIMGMATISM SOFT CONTACT LEN WHEN WORN ON A DAILY BASIS Bausch Health US, LLC $5,346 4

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 344 372 $131,356 $22,279
2022 8 324 351 $107,938 $19,744
2021 7 342 377 $109,345 $20,377
2020 5 263 286 $111,875 $20,768
Total Patients
1,273
Total Services
1,386
Medicare Billing
$83,168
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
92014 Established patient complete exam of visual system Office 2023 232 240 $101,554 $16,966 16.7%
92012 Established patient problem focused exam of visual system Office 2023 42 59 $17,442 $3,064 17.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 16 18 $4,230 $973.30 23.0%
92083 Exam of visual field with extended testing Office 2023 14 14 $2,840 $467.21 16.5%
92133 Imaging of optic nerve Office 2023 21 22 $2,510 $411.98 16.4%
92134 Imaging of retina Office 2023 19 19 $2,780 $397.49 14.3%
92014 Established patient complete exam of visual system Office 2022 118 118 $49,238 $9,136 18.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 106 113 $31,485 $5,669 18.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 21 34 $8,160 $1,369 16.8%
92012 Established patient problem focused exam of visual system Office 2022 16 19 $5,546 $1,198 21.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 12 12 $4,364 $883.71 20.3%
92083 Exam of visual field with extended testing Office 2022 19 19 $4,330 $669.89 15.5%
92134 Imaging of retina Office 2022 21 25 $3,455 $595.91 17.2%
92133 Imaging of optic nerve Office 2022 11 11 $1,360 $223.01 16.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 166 184 $51,520 $11,383 22.1%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2021 54 55 $25,850 $3,534 13.7%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 35 47 $11,280 $1,897 16.8%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 23 23 $9,200 $1,451 15.8%
92083 Measurement of field of vision during daylight conditions, extended examination Office 2021 17 17 $3,995 $794.40 19.9%
92134 Diagnostic imaging of retina Office 2021 20 24 $3,720 $676.83 18.2%
92133 Diagnostic imaging of optic nerve of eye Office 2021 27 27 $3,780 $640.68 16.9%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2020 166 177 $79,650 $14,699 18.5%
92012 Eye and medical examination for diagnosis and treatment, established patient Office 2020 38 50 $15,750 $2,911 18.5%
92004 Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits Office 2020 17 17 $9,095 $1,722 18.9%
92083 Measurement of field of vision during daylight conditions Office 2020 18 18 $4,140 $762.71 18.4%

About Dr. Michael Depaolis, O.D

Dr. Michael Depaolis, O.D is a Optometrist healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720084346.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Depaolis, O.D has received a total of $40,349 in payments from pharmaceutical and medical device companies, with $193.53 received in 2024. These payments were reported across 58 transactions from 20 companies. The most common payment nature is "" ($30,483).

As a Medicare-enrolled provider, Depaolis has provided services to 1,273 Medicare beneficiaries, totaling 1,386 services with total Medicare billing of $83,168. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Optometrist
  • Other Specialties Corneal and Contact Management
  • Location Rochester, NY
  • Active Since 06/28/2005
  • Last Updated 07/05/2023
  • Taxonomy Code 152W00000X
  • Entity Type Individual
  • NPI Number 1720084346

Products in Payments

  • BIOTRUE ONEDAY FOR ASTIGMATISM (Device) $30,483
  • XIIDRA (Drug) $5,754
  • MiSight Contact Lens (Device) $1,109
  • EYSUVIS (Drug) $784.25
  • Cequa (Drug) $217.12
  • IYUZEH (Drug) $202.19
  • INFUSE (Device) $200.83
  • Clariti Contact Lens (Device) $131.19
  • TearCare SmartLid (Device) $129.64
  • TEPEZZA (Drug) $124.99
  • AcrySof IQ PanOptix UV IOL (Device) $112.77
  • OMNI(R) SURGICAL SYSTEM (US) (Device) $112.20
  • CEREZYME (Drug) $109.02
  • CEQUA (Drug) $103.84
  • INVELTYS (Drug) $102.61
  • Multiple Brands Contact Lens (Device) $91.94
  • Tecnis Symfony IOL (Device) $87.00
  • VYZULTA (Drug) $77.96
  • PROLENSA (Drug) $70.86
  • ILUX (Device) $33.49

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Optometrist Doctors in Rochester